BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19076727)

  • 1. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.
    Kanstrup IL; Klausen TL; Bojsen-Møller J; Magnusson P; Zerahn B
    Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
    Paquet N; Albert A; Foidart J; Hustinx R
    J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is liver SUV stable over time in ¹⁸F-FDG PET imaging?
    Laffon E; Adhoute X; de Clermont H; Marthan R
    J Nucl Med Technol; 2011 Dec; 39(4):258-63. PubMed ID: 21878481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive correlation between serum liver enzyme levels and standard uptake values of liver on FDG-PET.
    Lin CY; Ding HJ; Lin T; Lin CC; Kuo TH; Kao CH
    Clin Imaging; 2010; 34(2):109-12. PubMed ID: 20189073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
    Abele JT; Fung CI
    Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
    Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
    AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.
    Lee SW; Nam SY; Im KC; Kim JS; Choi EK; Ahn SD; Park SH; Kim SY; Lee BJ; Kim JH
    Radiother Oncol; 2008 May; 87(2):211-6. PubMed ID: 18237806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of (18)F-FDG in the liver in hepatic steatosis.
    Keramida G; Potts J; Bush J; Verma S; Dizdarevic S; Peters AM
    AJR Am J Roentgenol; 2014 Sep; 203(3):643-8. PubMed ID: 25148170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic steatosis is associated with increased hepatic FDG uptake.
    Keramida G; Potts J; Bush J; Dizdarevic S; Peters AM
    Eur J Radiol; 2014 May; 83(5):751-5. PubMed ID: 24581596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
    Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
    Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG uptake and clearance in patients with compromised renal function.
    Akers SR; Werner TJ; Rubello D; Alavi A; Cheng G
    Nucl Med Commun; 2016 Aug; 37(8):825-32. PubMed ID: 27058366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET.
    Boktor RR; Walker G; Stacey R; Gledhill S; Pitman AG
    J Nucl Med; 2013 May; 54(5):677-82. PubMed ID: 23512357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG-PET/CT study.
    Liu G; Li Y; Hu P; Cheng D; Shi H
    Nucl Med Commun; 2015 Jul; 36(7):709-16. PubMed ID: 25757200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?
    Keramida G; Dizdarevic S; Bush J; Peters AM
    Eur Radiol; 2015 Sep; 25(9):2701-8. PubMed ID: 25899414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET reproducibility in tumor-bearing mice: comparing a traditional SUV approach with a tumor-to-brain tissue ratio approach.
    Busk M; Munk OL; Jakobsen S; Frøkiær J; Overgaard J; Horsman MR
    Acta Oncol; 2017 May; 56(5):706-712. PubMed ID: 28094665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas.
    Yamane T; Daimaru O; Ito S; Yoshiya K; Nagata T; Ito S; Uchida H
    J Nucl Med; 2004 Nov; 45(11):1838-42. PubMed ID: 15534052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hyperglycemia on brain and liver
    Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD
    Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
    Hofele C; Freier K; Thiele OC; Haberkorn U; Buchmann I
    Oral Oncol; 2009 Nov; 45(11):963-7. PubMed ID: 19665923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.